ChromaDex and the Scripps Research Institute collaborate
ChromaDex Corporation (CDXC) (Irvine, California, USA) has announced that it has collaborated with the Scripps Centre for Metabolomics (La Jolla, California, USA) to generate tandem mass spectrometry data for compounds from the ChromaDex natural products and phytochemical catalogue.
ChromaDex Corporation (CDXC) (Irvine, California, USA) has announced that it has collaborated with the Scripps Centre for Metabolomics (La Jolla, California, USA) to generate tandem mass spectrometry data for compounds from the ChromaDex natural products and phytochemical catalogue. There is currently limited information for natural products in the database. By expanding the population of data, it will increase the knowledge base for researchers to screen potential compounds for use in areas of clinical interest.
The Scripps METLIN Metabolite Database is a repository of metabolite information that includes tandem mass spectrometry data for over 55,000 compounds. It is a public, web-based database designed for the archiving, visualization and analysis of metabolite data.
Gary Siuzdak, PhD, senior director, Centre for Metabolomics and Mass Spectrometry Scripps Research Institute, commented, “We are very excited about expanding the METLIN metabolite database with the ChromaDex phytochemicals. METLIN is currently the largest repository of metabolite tandem mass spectrometry data. The importance in the ChromaDex/METLIN partnership is that it will facilitate metabolomics experiments around the world.”
Frank Jaksch, founder and CSO for ChromaDex, said, “Collaborating with Scripps Research Institute with our natural product libraries will further advance small molecule profiling to increase demand for natural product libraries through the ease of the internet to assist in finding candidate compounds for research and development.”
For more information please visit ref="http://www.chromadex.com">www.chromadex.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
